PositiveID's Implantable Microchip

PositiveID Makes All-stock Offer for Digital Angel

PositiveID makes all-stock offer for Digital Angel in proposed $14.5 million deal

September 16, 2010

AP - PositiveID Corp. said Thursday it is offering to acquire Digital Angel Corp., a company that provides technology for tracking people and animals, in an all-stock deal.

PositiveID, which makes microchips for medical uses, said it will offer Digital Angel shareholders .67 share of its own common stock for reach Digital Angel share they hold.

Based on PositiveID's closing share price Thursday of 77 cents, the deal would value Digital Angel at roughly $14.5 million, or 52 cents per share.

That's a premium of 33 percent over Digital Angel's closing share price Wednesday of 39 cents. The company said its board will consider the bid.

After the offer Thursday, Digital Angel's stock jumped 10.8 cents, or 28 percent, to close at 49.8 cents.

PositiveID Corporation Presents Offer to Acquire Digital Angel Corporation

September 16, 2010

Reuters - PositiveID Corporation announced that it has presented an offer to the Digital Angel Corporation (Digital Angel) board of directors to purchase all the outstanding shares of Digital Angel common stock for $0.60 per share, representing a 60% premium to Digital Angel's average closing price for the 20 trading days ending on September 14. Based upon this price, PositiveID proposes to exchange 0.67 share of its common stock for each outstanding share of Digital Angel. The merger is expected to be immediately accretive to PositiveID.

PositiveID Corporation Agrees to Sell Health Link Personal Health Record Business

September 8, 2010

Reuters - PositiveID Corporation announced that it has agreed to sell its Health Link personal health record business for $1 million to Health Plexus, LLC. The Company will also retain the right to royalties on future Health Link revenues. Health Link is the Company's web-based personal health record (PHR), which is non-core to the Company's primary HealthID division. HealthID develops and markets unique medical devices, with a focus on diabetes management, and rapid medical testing products. The $1 million purchase price of the Health Link business will be structured in the form of a Note.